|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 04:04PM
|
|
Re: Trial Status
|
3
|
Resverlogix Corp.
|
Jul 25, 2021 09:05PM
|
|
Re: Insider Selling
|
3
|
Resverlogix Corp.
|
Jul 11, 2019 09:10PM
|
|
Re: Received a response....Third Eye Loan Balance
|
3
|
Resverlogix Corp.
|
Jul 14, 2019 11:00PM
|
|
Re: Right of first refusal
|
3
|
Resverlogix Corp.
|
Mar 03, 2019 11:18PM
|
|
Re: Volume
|
3
|
Resverlogix Corp.
|
Mar 15, 2021 11:25AM
|
|
Re: Right of first refusal
|
3
|
Resverlogix Corp.
|
Mar 04, 2019 12:07AM
|
|
Re: Response & what I will attempt...
|
3
|
Zenith Epigenetics
|
Aug 15, 2020 03:03PM
|
|
Re: TD Zenith Capital Corp | Grey Market : ZHCLF
|
3
|
Zenith Epigenetics
|
Oct 19, 2020 04:24PM
|
|
Re: Shenzhen Hepalink-Warrants Expiration
|
3
|
Resverlogix Corp.
|
Feb 05, 2022 03:40PM
|
|
Re: New trial
|
3
|
Zenith Epigenetics
|
May 29, 2021 10:08AM
|
|
Re: I'm glad dosing has begun... How long until results...
|
3
|
Resverlogix Corp.
|
Jan 20, 2022 08:32PM
|
|
Re: RVX Long Covid Trial
|
3
|
Resverlogix Corp.
|
May 29, 2023 02:37PM
|
|
Exempt Distribution
|
3
|
Resverlogix Corp.
|
Mar 06, 2019 12:02AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Mar 31, 2020 02:46AM
|
|
Re: Thar she blows!
|
3
|
Resverlogix Corp.
|
May 20, 2021 04:50PM
|
|
Re: Warrant Exercise Incentive Program
|
3
|
Resverlogix Corp.
|
Nov 26, 2019 11:09AM
|
|
Re: Outstanding Warrants
|
3
|
Resverlogix Corp.
|
May 29, 2019 02:37PM
|
|
Re: Rules on Disclosure
|
3
|
Resverlogix Corp.
|
Sep 26, 2019 11:29PM
|
|
Re: Estimated Glomerular Filtration Rate
|
3
|
Resverlogix Corp.
|
Nov 17, 2019 06:02PM
|
